Navigation Links
New Research Could Expand Availability of Light-Based Mesothelioma Therapy, According to Surviving Mesothelioma
Date:7/14/2014

Raleigh, NC (PRWEB) July 14, 2014

The NIH is giving $8 million dollars to researchers at the University of Pennsylvania to fund a clinical trial on light-based therapy in mesothelioma surgical patients. Click here to read Surviving Mesothelioma’s newly-posted article on the research.

Scientists at the University of Pennsylvania plan to use the grant to enroll 102 pleural mesothelioma study participants over the next four years. Patients will receive a photosensitizing drug prior to surgery. Then half will have the laser light treatment during their procedure while half will have only follow-up chemotherapy.

“This trial represents a major step in understanding the combination of treatment modalities that will offer patients the best hope for survival and extended remission,” said lead investigator Eli Glatstein, MD.

Previous University of Pennsylvania studies of PDT with lung-sparing surgery have produced remarkable survival rates of up to 41 months, even in patients with advanced mesothelioma.

“PDT is an exciting emerging therapy that is currently not widely available for mesothelioma treatment,” says Alex Strauss, Managing Editor of Surviving Mesothelioma. “If the results of these new NIH-funded studies are as encouraging as the previous studies of PDT at Penn, more patients who need it may get access to this therapy.”

For details of the new PDT research at Penn, see NIH Grant May Help Validate Light-Based Therapy for Mesothelioma now available on the Surviving Mesothelioma website.

“Penn Mesothelioma Program Receives $8 Million NCI Grant to Study Effects of Photodynamic Therapy Plus Surgery on Patient Survival and Disease Progression”, July 10, 2014, News Release, University of Pennsylvania website, http://www.uphs.upenn.edu/news/News_Releases/2014/07/meso/

For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Read the full story at http://www.prweb.com/releases/2014/07/prweb12009999.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stanford researchers invent nanotech microchip to diagnose type-1 diabetes
2. Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld
3. Global Cognitive Assessment & Training Market: 27.3% CAGR to 2018 Says a New Research Report Available at LifeScienceIndustryResearch.com
4. Casinos in Australia Industry Market Research Report Now Updated by IBISWorld
5. Floor-Grade Instruments Procurement Category Market Research Report from IBISWorld has Been Updated
6. World Virology and Bacteriology Testing Sector Discussed in Comprehensive VPG Research Report Published at MarketPublishers.com
7. Corn Farming in Canada Industry Market Research Report Now Available From IBISWorld
8. Organic Crop Farming in Australia Industry Market Research Report Now Available from IBISWorld
9. Researchers Assess New Way to Boost Polio Immunity
10. USC stem cell researcher targets the seeds of breast cancer metastasis
11. Recent Fourth Phase Water Discoveries Alter Basic Understanding of Life, Claims Researcher on Sharon Kleyne Hour
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... March 28, 2017 , ... ... dedicated to advancing the science and clinical practice of radiosurgery, announced today ... Registry, a multi-institutional, observational registry established to standardize data collection from patients ...
(Date:3/28/2017)... Wallingford, CT (PRWEB) , ... March 28, 2017 ... ... hemostatic devices, announces today that the University of Pittsburgh Medical Center (UPMC) will ... Central and Western Pennsylvania. , The program, developed in association with efforts by ...
(Date:3/28/2017)... VA (PRWEB) , ... March 28, 2017 , ... The ... Still, MHA, FRBMA, has begun to serve as its new executive director. Mr. Still ... the Executive Search Committee. , “Bob, as he is known to our members, ...
(Date:3/28/2017)... ... March 28, 2017 , ... Qualidigm ... its corporate headquarters to a new, more expansive office space in order to ... Qualidigm purchased a distressed office building in Wethersfield, Conn. located at 936 Silas ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... of corrosive ions found in power plant water and steam. , Chlorides and ... turbines and boilers, leading to extensive maintenance and unplanned shutdowns. Monitoring these ions ...
Breaking Medicine News(10 mins):
(Date:3/29/2017)... 2017 Research and Markets has announced the ... Market Outlook: 2016-2022" report to their offering. ... The global patient safety and ... delivery, end-user, and geography. Patient safety has become ... The field has developed significantly in the last decade and is ...
(Date:3/28/2017)... , March 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – ... the disease and global market trends of the Chemotherapy Induced Neutropenia ... , Europe ( France , ... Spain , UK) and Japan , ... and rest of the world (RoW). The Report covers ...
(Date:3/28/2017)...  Medeon Biodesign, Inc., a Taiwan ... announce that the Company led and successfully closed ... a San Jose, CA ... extremity applications.  The orthopedic extremity ... to procedure volume growth, lifestyle influences and favorable ...
Breaking Medicine Technology: